These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 19672087

  • 21. Tryptophan 64 --> arginine polymorphism of beta-3-adrenergic receptor in Chilean women with polycystic ovary syndrome.
    Pérez-Bravo F, Echiburú B, Maliqueo M, Santos JL, Sir-Petermann T.
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):126-31. PubMed ID: 15670186
    [Abstract] [Full Text] [Related]

  • 22. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.
    Legro RS, Kunselman AR, Dodson WC, Dunaif A.
    J Clin Endocrinol Metab; 1999 Jan; 84(1):165-9. PubMed ID: 9920077
    [Abstract] [Full Text] [Related]

  • 23. Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome.
    Yilmaz M, Bukan N, Ersoy R, Karakoç A, Yetkin I, Ayvaz G, Cakir N, Arslan M.
    Hum Reprod; 2005 Sep; 20(9):2414-20. PubMed ID: 15890734
    [Abstract] [Full Text] [Related]

  • 24. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
    Soares EM, Azevedo GD, Gadelha RG, Lemos TM, Maranhão TM.
    Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
    [Abstract] [Full Text] [Related]

  • 25. [Prevalence of the glucose metabolism disturbances in screening of adult inhabitants of Krakow].
    Szurkowska M, Szafraniec K, Gilis-Januszewska A, Pach D, Krzentowska A, Szybiński Z, Huszno B.
    Przegl Lek; 2006 Mar; 63(9):728-32. PubMed ID: 17479858
    [Abstract] [Full Text] [Related]

  • 26. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.
    Cheung LP, Ma RC, Lam PM, Lok IH, Haines CJ, So WY, Tong PC, Cockram CS, Chow CC, Goggins WB.
    Hum Reprod; 2008 Jun; 23(6):1431-8. PubMed ID: 18359783
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Insulin release and daily glucose change in polycystic ovary syndrome women with normal glucose tolerance].
    Tao MF, Zhu JP, Zhou J, Lu W, Qin W, Teng YC, Jia WP.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 17; 89(10):659-63. PubMed ID: 19595057
    [Abstract] [Full Text] [Related]

  • 35. [Comparison of HOMA IR with the minimal model for measuring insulin sensitivity in polycystic ovary syndrome].
    Amador N, Espinoza G, Guízar JM, González M, Alpízar M.
    Rev Invest Clin; 2001 Mar 17; 53(5):407-12. PubMed ID: 11795106
    [Abstract] [Full Text] [Related]

  • 36. Type II Diabetes Mellitus and impaired glucose tolerance in Yemen: prevalence, associated metabolic changes and risk factors.
    Al-Habori M, Al-Mamari M, Al-Meeri A.
    Diabetes Res Clin Pract; 2004 Sep 17; 65(3):275-81. PubMed ID: 15331208
    [Abstract] [Full Text] [Related]

  • 37. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study.
    Legro RS, Gnatuk CL, Kunselman AR, Dunaif A.
    J Clin Endocrinol Metab; 2005 Jun 17; 90(6):3236-42. PubMed ID: 15797965
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.